Inotek Pharmaceuticals Corporation Company Profile (NASDAQ:ITEK)

About Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation logoInotek Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. Its lead product candidate, trabodenoson, is a selective adenosine mimetic that the Company has designed to lower intraocular pressure (IOP) by restoring the eye's natural pressure control mechanism. The Company developed this molecule to selectively stimulate a particular adenosine subreceptor in the eye with the effect of augmenting the intrinsic function of the eye's trabecular meshwork (TM). Its product pipeline includes trabodenoson monotherapy delivered in an eye drop formulation, as well as a fixed-dose combination (FDC), of trabodenoson with latanoprost given once-daily (QD). The Company is evaluating the potential of trabodenoson to slow the loss of vision associated with glaucoma and degenerative retinal diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ITEK
  • CUSIP:
Key Metrics:
  • Previous Close: $1.63
  • 50 Day Moving Average: $1.782
  • 200 Day Moving Average: $5.948
  • 52-Week Range: $1.50 - $10.90
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.97
  • P/E Growth: 0.000
  • Market Cap: $43.76M
  • Outstanding Shares: 26,930,000
  • Beta: 3.38
Profitability:
  • Return on Equity: -39.18%
  • Return on Assets: -33.28%
Debt:
  • Debt-to-Equity Ratio: 0.57%
  • Current Ratio: 23.39%
  • Quick Ratio: 23.39%
Additional Links:
Companies Related to Inotek Pharmaceuticals Corporation:

Analyst Ratings

Consensus Ratings for Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $7.25 (353.13% upside)

Analysts' Ratings History for Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)
Show:
DateFirmActionRatingPrice TargetDetails
1/4/2017HC WainwrightReiterated RatingBuy$7.00View Rating Details
1/3/2017Canaccord GenuitySet Price TargetBuy$9.00View Rating Details
1/3/2017Piper Jaffray CompaniesDowngradeOverweight -> Neutral$3.00View Rating Details
12/1/2016Roth CapitalInitiated CoverageBuy$10.00View Rating Details
7/24/2015NomuraReiterated RatingBuy$13.00 -> $30.00View Rating Details
7/24/2015Cowen and CompanyReiterated RatingOutperform$15.00 -> $40.00View Rating Details
(Data available from 2/21/2015 forward)

Earnings

Earnings History for Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/21/2017        
8/10/2016Q2($0.40)($0.33)ViewN/AView Earnings Details
5/11/2016Q1($0.22)($0.38)ViewN/AView Earnings Details
3/23/2016Q4($0.37)($0.13)ViewN/AView Earnings Details
5/15/2015Q115($0.40)($0.21)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)
Current Year EPS Consensus Estimate: $-1.70 EPS
Next Year EPS Consensus Estimate: $-1.65 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20161($0.41)($0.41)($0.41)
Q1 20171($0.30)($0.30)($0.30)
Q2 20171($0.31)($0.31)($0.31)
Q3 20171($0.33)($0.33)($0.33)
Q4 20171($0.33)($0.33)($0.33)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)
Insider Ownership Percentage: 11.70%
Institutional Ownership Percentage: 81.49%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/6/2017David P. SouthwellInsiderBuy60,000$1.75$105,000.00View SEC Filing  
5/13/2016J Martin CarrollDirectorBuy10,000$9.03$90,300.00View SEC Filing  
2/23/2015Argeris N KarabelasDirectorBuy603,832$6.00$3,622,992.00View SEC Filing  
2/23/2015Park Bioventures Lp DevonMajor ShareholderBuy814,166$6.00$4,884,996.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)
DateHeadline
News IconInotek Pharmaceuticals Corp (NASDAQ:ITEK) Investor Alert ... - Digital Journal (NASDAQ:ITEK)
www.digitaljournal.com - February 20 at 5:28 PM
4-traders.com logoITEK The Law Offices of Vincent Wong Reminds Investors of Commencement of a.. (NASDAQ:ITEK)
www.4-traders.com - February 18 at 5:24 PM
businesswire.com logoITEK SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Inotek Pharmaceuticals Corporation and a Lead Plaintiff ... (NASDAQ:ITEK)
www.businesswire.com - February 18 at 5:24 PM
finance.yahoo.com logoITEK SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Inotek Pharmaceuticals Corporation and a Lead Plaintiff Deadline of March 7, 2017 (NASDAQ:ITEK)
finance.yahoo.com - February 17 at 5:24 PM
finance.yahoo.com logoINVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Inotek Pharmaceuticals Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:ITEK)
finance.yahoo.com - February 17 at 5:24 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Inotek Pharmaceuticals Corporation (ITEK) and Lead Plaintiff Deadline - March 7, 2017 (NASDAQ:ITEK)
us.rd.yahoo.com - February 16 at 4:52 PM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Inotek ... - Yahoo Finance (NASDAQ:ITEK)
finance.yahoo.com - February 15 at 9:09 PM
benzinga.com logoBragar Eagel & Squire, P.C. Reminds Investors... (NASDAQ:ITEK)
www.benzinga.com - February 15 at 5:30 AM
News IconStock Levels in Review for Inotek Pharmaceuticals Corporation (ITEK) - Rives Journal (NASDAQ:ITEK)
rivesjournal.com - February 15 at 12:27 AM
prnewswire.com logoITEK INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Inotek ... - PR Newswire (press release) (NASDAQ:ITEK)
www.prnewswire.com - February 15 at 12:27 AM
News IconEPS Of Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) At $-0.44 - Stock Observer (NASDAQ:ITEK)
www.thestockobserver.com - February 15 at 12:27 AM
businesswire.com logoBragar Eagel & Squire, PC Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inotek ... - Business Wire (press release) (NASDAQ:ITEK)
www.businesswire.com - February 15 at 12:27 AM
4-traders.com logoPROBILITY MEDIA CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) (NASDAQ:ITEK)
www.4-traders.com - February 14 at 7:25 PM
businesswire.com logoBragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inotek Pharmaceuticals Corporation (ITEK) and Encourages Investors with Losses ... (NASDAQ:ITEK)
www.businesswire.com - February 14 at 7:25 PM
finance.yahoo.com logoBragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inotek Pharmaceuticals Corporation (ITEK) and Encourages Investors with Losses to Contact the Firm (NASDAQ:ITEK)
finance.yahoo.com - February 14 at 7:25 PM
News IconMarket Scout: Checking the Levels for Inotek Pharmaceuticals ... - Davidson Register (NASDAQ:ITEK)
davidsonregister.com - February 11 at 4:46 AM
finance.yahoo.com logoInotek Pharmaceuticals to Present at the BIO CEO and Investor Conference (NASDAQ:ITEK)
finance.yahoo.com - February 10 at 6:45 PM
News IconWatching Technical Levels on Shares of Inotek Pharmaceuticals Corporation (ITEK) - Rives Journal (NASDAQ:ITEK)
rivesjournal.com - February 7 at 7:17 PM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Inotek Pharmaceuticals Corporation (ITEK) and Lead Plaintiff Deadline: March 7, 2017 (NASDAQ:ITEK)
finance.yahoo.com - February 7 at 7:17 PM
finance.yahoo.com logoINVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Inotek Pharmaceuticals Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:ITEK)
finance.yahoo.com - February 7 at 7:17 PM
businesswire.com logoBragar Eagel & Squire, PC Announces That a Class Action Lawsuit Has Been Filed Against Inotek Pharmaceuticals ... - Business Wire (press release) (NASDAQ:ITEK)
www.businesswire.com - February 6 at 11:07 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors It Has Filed a Class Action Lawsuit Against … (NASDAQ:ITEK)
finance.yahoo.com - February 6 at 6:06 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors It Has Filed a Class Action Lawsuit Against Inotek Pharmaceuticals Corporation and a Lead Plaintiff Deadline of March 7, 2017 (NASDAQ:ITEK)
finance.yahoo.com - February 6 at 6:06 PM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Inotek Pharmaceuticals Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:ITEK)
finance.yahoo.com - February 6 at 6:06 PM
finance.yahoo.com logoBragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Inotek Pharmaceuticals Corporation (ITEK) and Encourages Investors to Contact the Firm (NASDAQ:ITEK)
finance.yahoo.com - February 6 at 6:06 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Inotek ... - Yahoo Finance (NASDAQ:ITEK)
finance.yahoo.com - February 2 at 11:42 PM
businesswire.com logoITEK SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Inotek Pharmaceuticals Corporation and a Lead Plaintiff Deadline of March ... (NASDAQ:ITEK)
www.businesswire.com - February 2 at 6:42 PM
finance.yahoo.com logoIMPORTANT INOTEK INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities … (NASDAQ:ITEK)
finance.yahoo.com - February 2 at 6:42 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Inotek Pharmaceuticals Corporation (ITEK) and Lead Plaintiff Deadline: March 7, 2017 (NASDAQ:ITEK)
us.rd.yahoo.com - February 2 at 6:42 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Inotek Pharmaceuticals Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:ITEK)
finance.yahoo.com - February 2 at 6:42 PM
finance.yahoo.com logoIMPORTANT INOTEK INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the District of Massachusetts against Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)
finance.yahoo.com - February 2 at 6:42 PM
News IconRelative Strength Index Review on Shares of Inotek Pharmaceuticals Corporation (ITEK) - Sherwood Daily (NASDAQ:ITEK)
sherwooddaily.com - January 30 at 9:34 PM
News IconAre Insiders Bumping Up Their Positions in Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) - Wall Street Beacon (NASDAQ:ITEK)
wsbeacon.com - January 30 at 9:34 PM
News IconHigh Volatility Creating Buzz Mid-Session For Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) - Wall Street Beacon (NASDAQ:ITEK)
wsbeacon.com - January 28 at 1:09 AM
globenewswire.com logoITEK INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Inotek ... - GlobeNewswire (press release) (NASDAQ:ITEK)
globenewswire.com - January 28 at 1:09 AM
businesswire.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Inotek Pharmaceuticals Corporation and Encourages Investors with Losses to Contact ... (NASDAQ:ITEK)
www.businesswire.com - January 27 at 8:06 PM
finance.yahoo.com logoITEK INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Inotek Pharmaceuticals Corporation and a Lead Plaintiff Deadline of March 7, 2017 (NASDAQ:ITEK)
finance.yahoo.com - January 27 at 8:06 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Inotek Pharmaceuticals Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:ITEK)
finance.yahoo.com - January 27 at 8:06 PM
News IconEarnings in Full Force, Analysts Take Aim at Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) - Wall Street Beacon (NASDAQ:ITEK)
wsbeacon.com - January 26 at 7:44 PM
News IconTechnical Action Update on Shares of Inotek Pharmaceuticals Corporation (ITEK) - Sherwood Daily (NASDAQ:ITEK)
sherwooddaily.com - January 26 at 7:44 PM
globenewswire.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Inotek ... - GlobeNewswire (press release) (NASDAQ:ITEK)
globenewswire.com - January 26 at 7:44 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Inotek Pharmaceuticals Corporation (ITEK) & Lead Plaintiff Deadline: March 7, 2017 (NASDAQ:ITEK)
finance.yahoo.com - January 26 at 7:44 PM
finance.yahoo.com logoEQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Inotek Pharmaceuticals Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:ITEK)
finance.yahoo.com - January 26 at 7:44 PM
openpr.com logoInotek Pharmaceuticals Corp (NASDAQ:ITEK) Investor Lawsuit alleges False and Misleading Statements (NASDAQ:ITEK)
www.openpr.com - January 24 at 6:44 PM
News IconMA Levels in Review for Inotek Pharmaceuticals Corporation (ITEK) - Sherwood Daily (NASDAQ:ITEK)
sherwooddaily.com - January 23 at 6:19 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Class Action Lawsuit Against Inotek Pharmaceuticals Corporation and a Lead Plaintiff Deadline of March 7, 2017 – ITEK (NASDAQ:ITEK)
finance.yahoo.com - January 23 at 6:19 PM
News IconNews Impact Score Of Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) Set At 0 - Stock Observer (NASDAQ:ITEK)
www.thestockobserver.com - January 22 at 10:50 PM
News IconNext Weeks Broker Price Targets For Inotek Pharmaceuticals Corporation (ITEK) (NASDAQ:ITEK)
flapship.com - January 21 at 5:49 PM
News IconNASDAQ:ITEK Investor Alert: Lawsuit alleges Misleading Statements by Inotek Pharmaceuticals Corp (NASDAQ:ITEK)
www.groundreport.com - January 20 at 9:09 PM
News IconRelative Strength Points to Oversold Range For Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) - Wall Street Beacon (NASDAQ:ITEK)
wsbeacon.com - January 20 at 5:50 AM

Social

What is Inotek Pharmaceuticals Corporation's stock symbol?

Inotek Pharmaceuticals Corporation trades on the NASDAQ under the ticker symbol "ITEK."

Where is Inotek Pharmaceuticals Corporation's stock going? Where will Inotek Pharmaceuticals Corporation's stock price be in 2017?

4 brokers have issued 12-month target prices for Inotek Pharmaceuticals Corporation's shares. Their predictions range from $3.00 to $10.00. On average, they expect Inotek Pharmaceuticals Corporation's stock price to reach $7.25 in the next twelve months.

When will Inotek Pharmaceuticals Corporation announce their earnings?

Inotek Pharmaceuticals Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, March, 21st 2017.

Who owns Inotek Pharmaceuticals Corporation stock?

Inotek Pharmaceuticals Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include Franklin Resources Inc. (4.90%), State Street Corp (0.99%), FT Options LLC (0.67%), Oxford Asset Management (0.38%), New Leaf Venture Partners L.L.C. (0.23%) and Dimensional Fund Advisors LP (0.11%). Company insiders that own Inotek Pharmaceuticals Corporation stock include Argeris N Karabelas, David P Southwell, J Martin Carroll and Park Bioventures Lp Devon.

Who sold Inotek Pharmaceuticals Corporation stock? Who is selling Inotek Pharmaceuticals Corporation stock?

Inotek Pharmaceuticals Corporation's stock was sold by a variety of institutional investors in the last quarter, including GRT Capital Partners L.L.C. and Franklin Resources Inc..

Who bought Inotek Pharmaceuticals Corporation stock? Who is buying Inotek Pharmaceuticals Corporation stock?

Inotek Pharmaceuticals Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Oxford Asset Management, New Leaf Venture Partners L.L.C., FT Options LLC, Trexquant Investment LP and State Street Corp. Company insiders that have bought Inotek Pharmaceuticals Corporation stock in the last two years include Argeris N Karabelas, David P Southwell, J Martin Carroll and Park Bioventures Lp Devon.

How do I buy Inotek Pharmaceuticals Corporation stock?

Shares of Inotek Pharmaceuticals Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Inotek Pharmaceuticals Corporation stock cost?

One share of Inotek Pharmaceuticals Corporation stock can currently be purchased for approximately $1.60.

Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) Chart for Tuesday, February, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)

Earnings History Chart

Earnings by Quarter for Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)

Dividend History Chart

Dividend Payments by Quarter for Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)

Last Updated on 2/21/2017 by MarketBeat.com Staff